Google Alert - "Myeloproliferative neoplasms" OR "polycythemia vera" OR myelofibrosis OR "essential thrombocythemia" google.com

Myelofibrosis Market Expected to Surpass USD 5.3 Billion by 2034, estimates DelveInsight

google.com·18w

NFκB/IL-6/JAK2/STAT axis in myelofibrosis is a key vulnerability that is targetable and ...

google.com·18w

New targeted treatment offers hope for people with myelofibrosis

google.com·18w

Australian researchers develop targeted therapy for rare blood cancer

google.com·18w

PharmaEssentia Announces Positive Topline Phase 2b Data from EXCEED-ET Study ...

google.com·18w

Australian Scientists Uncover Promising Therapy for Myelofibrosis

google.com·18w

Galecto Showcases New mutCALR MPN Pipeline at JPM

google.com·18w

Disc Medicine Highlights Recent Achievements and Key Business Objectives and ...

google.com·18w

Australian team develops targeted therapy for rare blood cancer

google.com·18w

Disc Medicine receives FDA priority review voucher for bitopertin

google.com·18w

Investigative Mutated CALR Inhibitor Shows Promise in MPNs

google.com·18w

Protagonist Therapeutics, Inc Updates on Clinical Developments and Collaborations

google.com·18w

PharmaEssentia Announces Positive Topline Phase 2b Data from EXCEED-ET Study ...

google.com·18w

PharmaEssentia announces positive topline Phase 2B data from Exceed-Et study evaluating ...

google.com·18w

Karyopharm Announces Preliminary Unaudited 2025 Revenue and Reiterates Expectation ...

google.com·18w

Karyopharm expects phase 3 trial data in myelofibrosis by March

google.com·18w

New Australian research offers hope for rare blood cancer patients

google.com·18w

GLP-1a Therapy Improves Survival in Patients with PV

google.com·18w

Australian scientists unveil targeted immunotherapy strategy for myelofibrosis

google.com·18w

A Decade of Patient Proactivity and Physician Partnership

google.com·18w

Log in to enable infinite scrolling